Page last updated: 2024-08-25

adriamycinol and Colorectal Neoplasms

adriamycinol has been researched along with Colorectal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chandler, LH; de Bruijn, P; Jewell, RC; Loos, WJ; Nooter, K; Paul, EM; Planting, AS; Sparreboom, A; van der Burg, ME; van der Gaast, A; Verweij, J; Wissel, PS	1

Trials

1 trial(s) available for adriamycinol and Colorectal Neoplasms

Article	Year
Clinical pharmacokinetics of doxorubicin in combination with GF120918, a potent inhibitor of MDR1 P-glycoprotein. Anti-cancer drugs, 1999, Volume: 10, Issue:8 Topics: Acridines; Adult; Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Platelets; Colorectal Neoplasms; Cross-Over Studies; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Isoquinolines; Male; Middle Aged; Neutrophils; Tetrahydroisoquinolines; Time Factors	1999

Article

Year

Clinical pharmacokinetics of doxorubicin in combination with GF120918, a potent inhibitor of MDR1 P-glycoprotein.

Anti-cancer drugs, 1999, Volume: 10, Issue:8

Topics: Acridines; Adult; Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Platelets; Colorectal Neoplasms; Cross-Over Studies; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Isoquinolines; Male; Middle Aged; Neutrophils; Tetrahydroisoquinolines; Time Factors

1999